Topical treatment for controlling malignant wound odour. Winardi A, Irwan A The prevalence of malignant wounds is currently unknown. However, it is estimated that around 5%–10% of breast cancer cases, sarcomas and melanomas result in malignant wounds. This article describes a study which identified and analysed the scientific evidence on the use of topical treatments for controlling odour from malignant wounds. DOI: 10.35279/jewma201910.01
Psychological factors associated with malignant fungating breast wounds. Robinson P, Holloway S Malignant fungating wounds (MFWs) can be a distressing consequence of breast cancer. Although the true prevalence of MFWs is unknown, existing figures suggest that rates may be as high as 62%, and this figure increases with age. Multiple studies have examined the psychological consequences of MFWs in the breast. This review presents a summary of some of the research to examine the role of specialist wound advice. DOI: 10.35279/jewma201910.02
Effects of radiotherapy on wound healing. Robinson P, Holloway S Radiotherapy is widely used to treat for cancer. This therapy aims to kill cancer cells while sparing the surrounding tissue where possible. Radiotherapy can impair the normal healing process in any phase of tissue repair. This review discusses the acute and late effects of radiotherapy and relates them to wound healing. DOI: 10.35279/jewma201910.03